Corvus Pharmaceuticals (CRVS) EBITDA (2015 - 2026)
Corvus Pharmaceuticals' EBITDA came in at -$19.26 million for Q2 2026, compared with -$10.23 million a year earlier.
Powered by 
Analysis
Corvus Pharmaceuticals (CRVS) EBITDA (2015 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Corvus Pharmaceuticals reported EBITDA of -$54.89 million; for FY2023, it came in at -$23.26 million.
- Going back by year, EBITDA was -$32.2 million in FY2022, -$38.17 million in FY2021, -$43.13 million in FY2020 and -$48.11 million in FY2019.
- The Q2 2026 figure represents the lowest quarterly EBITDA in data going back to Q1 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Corvus Pharmaceuticals | 943.08 Mn | 431.52 Mn | - | -19.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -19.26 Mn |
| Mar 31, 2026 | -14.85 Mn |
| Dec 31, 2025 | -12.19 Mn |
| Sep 30, 2025 | -10.54 Mn |
| Jun 30, 2025 | -10.23 Mn |
| Mar 31, 2025 | -9.90 Mn |
| Dec 31, 2024 | -8.09 Mn |
| Sep 30, 2024 | -7.23 Mn |
| Jun 30, 2024 | -5.91 Mn |
| Mar 31, 2024 | -6.23 Mn |
| Dec 31, 2023 | -5.62 Mn |
| Sep 30, 2023 | -5.53 Mn |
| Jun 30, 2023 | -5.59 Mn |
| Mar 31, 2023 | -6.52 Mn |
| Dec 31, 2022 | -5.57 Mn |
| Sep 30, 2022 | -12.38 Mn |
| Jun 30, 2022 | -6.92 Mn |
| Mar 31, 2022 | -7.33 Mn |
| Dec 31, 2021 | -6.72 Mn |
| Sep 30, 2021 | -8.94 Mn |
API Access
Corvus Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=CRVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "CRVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=CRVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();